{"id":22121,"date":"2022-09-07T10:22:12","date_gmt":"2022-09-07T08:22:12","guid":{"rendered":"https:\/\/idibell.cat\/?p=22121"},"modified":"2022-09-07T10:22:12","modified_gmt":"2022-09-07T08:22:12","slug":"ledat-dinici-de-lesclerosi-multiple-ha-augmentat-en-les-ultimes-decades","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2022\/09\/ledat-dinici-de-lesclerosi-multiple-ha-augmentat-en-les-ultimes-decades\/","title":{"rendered":"L&#8217;edat d\u2019inici de l&#8217;esclerosi m\u00faltiple ha augmentat en les \u00faltimes d\u00e8cades"},"content":{"rendered":"<p>Un equip de l&#8217;IDIBELL i l&#8217;Hospital Universitari de Bellvitge (HUB) ha analitzat l&#8217;edat de presentaci\u00f3 dels primers s\u00edmptomes de l&#8217;esclerosi m\u00faltiple en 1622 pacients de l&#8217;hospital amb l\u2019inici de la malaltia entre el 1970 i el 2019. Els resultats, publicats a la revista <a href=\"https:\/\/www.msard-journal.com\/article\/S2211-0348(22)00609-5\/fulltext\"><em>Multiple Sclerosis and Related Disorders<\/em><\/a>, mostren que en les \u00faltimes d\u00e8cades ha anat augmentant progressivament l&#8217;edat en qu\u00e8 apareixen els primers s\u00edmptomes, <strong>passant dels 24 anys de mitjana als 34<\/strong>.<\/p>\n<p>L&#8217;esclerosi m\u00faltiple \u00e9s una malaltia cr\u00f2nica autoimmune provocada per la p\u00e8rdua de mielina de les neurones. Aquest estudi s\u2019ha portat a terme a la Unitat d\u2019Esclerosi M\u00faltiple del Servei de Neurologia de l\u2019Hospital de Bellvitge, liderat pel <strong>Dr. Sergio Mart\u00ednez-Yelamos<\/strong>, investigador principal de l&#8217;IDIBELL, coordinador de la Unitat d&#8217;Esclerosi M\u00faltiple del HUB i professor la Universitat de Barcelona. S\u2019ha realitzat en col\u00b7laboraci\u00f3 amb el Servei de Medicina Preventiva del mateix hospital. El treball s&#8217;ha centrat en <strong>l&#8217;esclerosi m\u00faltiple remitent-recurrent<\/strong>, la forma cl\u00ednica m\u00e9s comuna de la malaltia. Aquesta es caracteritza per l&#8217;aparici\u00f3 de brots en els quals es manifesten els s\u00edmptomes neurol\u00f2gics, seguit d&#8217;episodis de remissi\u00f3 m\u00e9s o menys llargs en qu\u00e8 aquests s\u00edmptomes desapareixen parcialment o totalment. Els brots, amb el temps, poden arribar a deixar seq\u00fceles irreversibles. Els primers s\u00edmptomes solen apar\u00e8ixer entre els 20 i els 40 anys, tot i que aquesta malaltia es pot manifestar a qualsevol edat.<\/p>\n<p>&#8220;<em>Desconeixem els motius pels quals ha augmentat l&#8217;edat d&#8217;aparici\u00f3 dels primers s\u00edmptomes<\/em> -comenta la <strong>Dra. Luc\u00eda Romero-Pinel<\/strong>, primera autora del treball, neur\u00f2loga de la Unitat d&#8217;Esclerosi M\u00faltiple del HUB i investigadora IDIBELL-. <em>Tot i aix\u00f2, hi ha diversos factors que creiem que podrien estar influint, com la disponibilitat de m\u00e8todes de diagn\u00f2stic m\u00e9s precisos, determinats canvis en l&#8217;estil de vida, o, una de les explicacions m\u00e9s plausibles, l&#8217;evoluci\u00f3 epidemiol\u00f2gica del virus d&#8217;Epstein-Barr<\/em>&#8220;.<\/p>\n<p>La infecci\u00f3 per aquest virus, comunament conegut com a virus de la mononucleosi, \u00e9s un factor de risc ambiental per desenvolupar esclerosi m\u00faltiple. Estudis recents mostren que la <strong>infecci\u00f3 pel virus d\u2019Epstein-Barr<\/strong> cada cop t\u00e9 lloc en edats m\u00e9s tardanes, segurament degut a la millora de les condicions socioecon\u00f2miques, el que en conseq\u00fc\u00e8ncia podria estar retardant l\u2019aparici\u00f3 de l\u2019esclerosi m\u00faltiple.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un estudi de l&#8217;IDIBELL i l&#8217;Hospital Universitari de Bellvitge ha detectat que l&#8217;edat en qu\u00e8 apareixen els primers s\u00edmptomes ha augmentat progressivament des del 1970 fins al 2019.<\/p>\n","protected":false},"author":8,"featured_media":22123,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[416,340,457],"tags":[],"class_list":["post-22121","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-malalties-neurologiques-i-neurogenetica","category-neurociencies","category-p-de-neurociencies"],"publishpress_future_action":{"enabled":false,"date":"2024-11-30 03:42:38","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=22121"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22121\/revisions"}],"predecessor-version":[{"id":22124,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22121\/revisions\/22124"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/22123"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=22121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=22121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=22121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}